6505--New base plus OY Contract for Nuclear Medicine Radiopharmaceuticals

Sources Sought Notice - MUSKOGEE VAMC NUCLEAR MEDICINE RADIOPHARMACEUTICALS Disclaimer: This Request for Information (RFI) is issued solely for market research information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. Responses to this notice are NOT offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. Information Requested from Industry: In response to the Sources Sought, interested Contractors shall submit the following information and any Capabilities/Qualifications Statement to include but not limited to an overview of proposed solution(s) and a description of the product your company possesses in accordance with the Statement of Work draft / Salient Characteristics List. Responses to market research table questionnaire shall be submitted. If this information is not provided, then it will be assumed the entire requirement cannot be met. Description of Requirement: The Department of Veterans Affairs, Veterans Health Administration (VHA), Network Contracting Office 19 (NCO 19) is conducting a market survey and is seeking potential sources for Nuclear Medicine Radiopharmaceuticals for the Jack C Montgomery (Muskogee) VA Medical Center. This sources Sought Notice is issued for information and planning purposes only. This is not a solicitation or a request for proposal and shall not be construed as an obligation or commitment by the Government. An award will not be made on any offers submitted in response to this notice, and it shall not be implied the Government is committed to providing any solicitation or award following this notice. The Government will not pay for any information received in response to this request, nor will the Government compensate a respondent for any costs incurred in developing the information provided. Requirement Item OR Services: Item # Product Description     1 Tc-99m Flood ( 2 mCi point source) (daily ) 1 dose   2 Tc-99m Linearity 250 mCi 4 dose   3 Tc-99m Linearity 4 mCi 4 dose   4 Tc-99m Cardiolite 1 dose   5 Tc-99m Sestamibi (generic) 2000 dose   6 Tc-99m MAA 50 dose   7 Tc-99m MAA(110K particles) 10 dose   8 Tc-99m MDP 330 dose   9 Tc-99m HDP 1 dose   10 Tc-99m Mebrofenin 150 dose   11 Tc-99m DTPA GFR 10 dose   12 Tc-99m DTPA Brain 5 dose   13 Tc-99m DTPA CSF 1 dose   14 Tc-99m DTPA Vent 50 dose   15 Tc-99m DMSA 5 dose   16 Tc-99m Mag-3 30 dose   17 Tc-99m Pertechnetate < 50 mCi See below See below   17a 35 mCi 30 dose   17b 30 mCi 5 dose   17c 25 mCi 50 dose   17d 10 mCi 5 dose   17e 5 mCi 5 dose   19 Tc Brain Imaging agent (pricing for only one agent is permissible if contractor cannot supply both agents) See below See below   19a TC 99m Ceretec (brain) 1 dose   20 Tc-99m Ceretec (WBC) 5 dose   21 Tc-99m Sulfur Colloid filtered 30 dose   22 Tc-99m Sulfur Colloid unfiltered 20 dose   23 Tc-99m Myoview 1 dose   24 Tc-99m Pyrophosphate 1 dose   25 Ga-67 Citrate 10 mCi dose 5 dose   26 I-131 Therapy Capsules/liquid - various doses See below See below   26a 150 mCi capsule/liquid 1 dose   26b 100 mCi capsule/liquid 1 dose   26c 200 mCi capsule/liquid 3 dose 26d 30 mCi capsule/liquid 10 dose   26e 15 mCi capsule/liquid 10 dose   27 I-131 Diagnostic CAP 10 uCi 5 Dose   28 I-131 WB DOSE 3 mCi dose 5 Dose   29 I-123 CAP (0.1 mCi) 30 Dose   30 I-123 CAP (0.2 mCi) 30 dose   31 In-111 Octreoscan 2 dose   32 In-111 DTPA 5 dose   33 In-111 Oxine (WBC) 20 dose   34 AeroSol Vent Replacement kits (or similar) 60 each   35 Kinevac Vials (when available) 150 vial   36 PYP Vials 50 vial   37 Ultratag 20 vial   38 Ga-67 QC Source 10 uCi 1 dose   39 In-111 QC Source 10 uCi 1 dose   40 I-123 QC Source 10 uCi 1 liquid/solid   41 I-131 QC Source 10 uCi 1 liquid/solid   42 Additional Routine delivery charge (7am-4:30pm) 25 service          ANCILLARY SUPPLIES Market Quote    43 Cobalt Sheet Source 1 each    price - not included in price of contract Removal of Spent sources also should be included in the price.           REMOVAL OF RADIOACTIVE WASTE     44 Removal of radioactive waste, including syringes and vials no longer used   All doses coming from pharmacy. Required Salient Characteristics OR SOW Requirements: The Department of Veterans Affairs, VA Medical Center, Muskogee Nuclear Medicine Service requires the contractor to provide the commodity of radiopharmaceuticals and any needed sources to be used with a SPECT & SPECT/CT imaging systems. Vendor must be within local area (50 miles) in order to meet time constraints of delivery requirements. In response to this announcement, please provide the information requested below requested in this market research table questionnaire. If this information is not provided, then it wil